Form 8-K - Current report:
SEC Accession No. 0001213900-25-035535
Filing Date
2025-04-25
Accepted
2025-04-25 16:03:11
Documents
39
Period of Report
2025-04-22
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0239321-8k_cero.htm   iXBRL 8-K 31782
2 CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF THE SERIES ea023932101ex3-1_cero.htm EX-3.1 295964
3 INVESTOR PRESENTATION, DATED APRIL 2025. ea023932101ex99-1_cero.htm EX-99.1 36335
4 GRAPHIC ex99-1_001.jpg GRAPHIC 491560
5 GRAPHIC ex99-1_002.jpg GRAPHIC 1614527
6 GRAPHIC ex99-1_003.jpg GRAPHIC 685983
7 GRAPHIC ex99-1_004.jpg GRAPHIC 821789
8 GRAPHIC ex99-1_005.jpg GRAPHIC 503416
9 GRAPHIC ex99-1_006.jpg GRAPHIC 603587
10 GRAPHIC ex99-1_007.jpg GRAPHIC 292685
11 GRAPHIC ex99-1_008.jpg GRAPHIC 442152
12 GRAPHIC ex99-1_009.jpg GRAPHIC 517305
13 GRAPHIC ex99-1_010.jpg GRAPHIC 600213
14 GRAPHIC ex99-1_011.jpg GRAPHIC 420979
15 GRAPHIC ex99-1_012.jpg GRAPHIC 550360
16 GRAPHIC ex99-1_013.jpg GRAPHIC 886608
17 GRAPHIC ex99-1_014.jpg GRAPHIC 520302
18 GRAPHIC ex99-1_015.jpg GRAPHIC 442790
19 GRAPHIC ex99-1_016.jpg GRAPHIC 444098
20 GRAPHIC ex99-1_017.jpg GRAPHIC 418563
21 GRAPHIC ex99-1_018.jpg GRAPHIC 409022
22 GRAPHIC ex99-1_019.jpg GRAPHIC 386671
23 GRAPHIC ex99-1_020.jpg GRAPHIC 759884
24 GRAPHIC ex99-1_021.jpg GRAPHIC 674603
25 GRAPHIC ex99-1_022.jpg GRAPHIC 455113
26 GRAPHIC ex99-1_023.jpg GRAPHIC 605020
  Complete submission text file 0001213900-25-035535.txt   19333488

Data Files

Seq Description Document Type Size
27 XBRL SCHEMA FILE cero-20250422.xsd EX-101.SCH 3537
28 XBRL DEFINITION FILE cero-20250422_def.xml EX-101.DEF 26594
29 XBRL LABEL FILE cero-20250422_lab.xml EX-101.LAB 36616
30 XBRL PRESENTATION FILE cero-20250422_pre.xml EX-101.PRE 25218
41 EXTRACTED XBRL INSTANCE DOCUMENT ea0239321-8k_cero_htm.xml XML 5804
Mailing Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080 650-407-2376
CERO THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001870404 (see all company filings)

EIN.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40877 | Film No.: 25873722
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)